Literature DB >> 9092576

Human dipeptidyl-peptidase I. Gene characterization, localization, and expression.

N V Rao1, G V Rao, J R Hoidal.   

Abstract

Dipeptidyl-peptidase I, a lysosomal cysteine proteinase, is important in intracellular degradation of proteins and appears to be a central coordinator for activation of many serine proteinases in immune/inflammatory cells. Little is known about the molecular genetics of the enzyme. In the present investigation the gene for dipeptidyl-peptidase I was cloned and characterized. The gene spans approximately 3.5 kilobases and consists of two exons and one intron. The genomic organization is distinct from the complex structures of the other members of the papain-type cysteine proteinase family. By fluorescence in situ hybridization, the gene was mapped to chromosomal region 11q14.1-q14.3. Analysis of the sequenced 5'-flanking region revealed no classical TATA or CCAAT box in the GC-rich region upstream of cap site. A number of possible regulatory elements that could account for tissue-specific expression were identified. Northern analyses demonstrated that the dipeptidyl-peptidase I message is expressed at high levels in lung, kidney, and placenta, at moderate to low levels in many organs, and at barely detectable levels in the brain, suggesting tissue-specific regulation. Among immune/inflammatory cells, the message is expressed at high levels in polymorphonuclear leukocytes and alveolar macrophages and their precursor cells. Treatment of lymphocytes with interleukin-2 resulted in a significant increase in dipeptidyl-peptidase I mRNA levels, suggesting that this gene is subjected to transcriptional regulation. The results provide initial insights into the molecular basis for the regulation of human dipeptidyl-peptidase I.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092576     DOI: 10.1074/jbc.272.15.10260

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses.

Authors:  Veronica Herías; Erik A L Biessen; Cora Beckers; Dianne Delsing; Mengyang Liao; Mat J Daemen; Christine C T N Pham; Sylvia Heeneman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-13       Impact factor: 8.311

2.  Mutations of the cathepsin C gene are responsible for Papillon-Lefèvre syndrome.

Authors:  T C Hart; P S Hart; D W Bowden; M D Michalec; S A Callison; S J Walker; Y Zhang; E Firatli
Journal:  J Med Genet       Date:  1999-12       Impact factor: 6.318

3.  Papillon-Lefevre Syndrome In An Adolescent Female: A Case Study.

Authors:  M J Jijin; H P Jaishankar; Veena Sathya Narayaran; Krupashankar Rangaswamy; Kavitha Ankanathapura Puthaswamy
Journal:  J Clin Diagn Res       Date:  2015-05-01

4.  Novel cathepsin C mutation in a Brazilian family with Papillon-Lefèvre syndrome: case report and mutation update.

Authors:  Debora Pallos; Ana Carolina Acevedo; Heliana Dantas Mestrinho; Ilia Cordeiro; Thomas C Hart
Journal:  J Dent Child (Chic)       Date:  2010 Jan-Apr

5.  Identification of cathepsin C mutations in ethnically diverse papillon-Lefèvre syndrome patients.

Authors:  P S Hart; Y Zhang; E Firatli; C Uygur; M Lotfazar; M D Michalec; J J Marks; X Lu; B J Coates; W K Seow; R Marshall; D Williams; J B Reed; J T Wright; T C Hart
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

6.  Cathepsin C Aggravates Neuroinflammation Involved in Disturbances of Behaviour and Neurochemistry in Acute and Chronic Stress-Induced Murine Model of Depression.

Authors:  Yanli Zhang; Kai Fan; Yanna Liu; Gang Liu; Xiaohan Yang; Jianmei Ma
Journal:  Neurochem Res       Date:  2017-06-16       Impact factor: 3.996

7.  Free-thiol Cys331 exposed during activation process is critical for native tetramer structure of cathepsin C (dipeptidyl peptidase I).

Authors:  Martin Horn; Miroslav Baudys; Zdenek Voburka; Ivan Kluh; Jirí Vondrásek; Michael Mares
Journal:  Protein Sci       Date:  2002-04       Impact factor: 6.725

Review 8.  Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).

Authors:  Brice Korkmaz; Adam Lesner; Stephanie Letast; Yassir K Mahdi; Marie-Lise Jourdan; Sandrine Dallet-Choisy; Sylvain Marchand-Adam; Christine Kellenberger; Marie-Claude Viaud-Massuard; Dieter E Jenne; Francis Gauthier
Journal:  Semin Immunopathol       Date:  2013-02-06       Impact factor: 9.623

9.  Deficiency of cathepsin C ameliorates severity of acute pancreatitis by reduction of neutrophil elastase activation and cleavage of E-cadherin.

Authors:  Daniel S John; Julia Aschenbach; Burkhard Krüger; Matthias Sendler; F Ulrich Weiss; Julia Mayerle; Markus M Lerch; Ali A Aghdassi
Journal:  J Biol Chem       Date:  2018-11-19       Impact factor: 5.157

10.  Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16- monocyte subsets.

Authors:  Petronela Ancuta; Kuang-Yu Liu; Vikas Misra; Vanessa Sue Wacleche; Annie Gosselin; Xiaobo Zhou; Dana Gabuzda
Journal:  BMC Genomics       Date:  2009-08-27       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.